Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. With 50 years of experience and expertise Bachem provides products for research, clinical development and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services. Bachem operates internationally with headquarters in Switzerland and locations in Europe, the US and Asia. The company is listed on the SIX Swiss Exchange.
We stand for long-term partnerships and excellent service. Innovation and technological leadership are as important to us as quality and operational excellence. Our passionate and dedicated employees, along with our unique corporate culture are the foundation of our success.
TLDR: Semaglutide, a synthetic peptide, is a promising treatment for Diabetes type II and Obesity due to its ability to regulate blood sugar and appetite, and can be administered as a tablet instead of injection. 00:00 💡 Semaglutide is a peptide used in prescription medicines for Diabetes type II and Obesity, and medical specialists are excited about it. 00:36 🔍 Semaglutide is a peptide that mimics the function of a hormone in the body, stimulating insulin secretion, inhibiting glucagon, impacting appetite, and slowing down digestion. 01:15 📌 Semaglutide regulates blood sugar and appetite, reducing long-term damage in Diabetes type II and obese patients, and can be administered as a tablet instead of injection. 01:59 💉 Semaglutide is a synthetic peptide manufactured in Switzerland with high purity levels, used to help fight against Diabetes type II and Obesity.
